ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹4,539 Cr | ₹4,207 Cr | ₹3,823 Cr | ₹3,532 Cr | ₹2,928 Cr |
What is the latest Total Liabilities ratio of ABBOTT INDIA ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹4,539 Cr |
Mar2022 | ₹4,207 Cr |
Mar2021 | ₹3,823 Cr |
Mar2020 | ₹3,532 Cr |
Mar2019 | ₹2,928 Cr |
How is Total Liabilities of ABBOTT INDIA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹4,539 Cr | 7.88 | |
Mar2022 | ₹4,207 Cr | 10.06 | |
Mar2021 | ₹3,823 Cr | 8.22 | |
Mar2020 | ₹3,532 Cr | 20.65 | |
Mar2019 | ₹2,928 Cr | - |
Compare Total Liabilities of peers of ABBOTT INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ABBOTT INDIA | ₹54,616.3 Cr | -2% | -5.5% | 16.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
ABBOTT INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ABBOTT INDIA | -2% |
-5.5% |
16.8% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses